Mild Cognitive Impairment Clinical Trial
Official title:
Effects of Muscle Relaxation on Cognitive Function in Patients With Mild Cognitive Impairment and Early Stage Dementia.
Muscle relaxation has been reported to be effective in alleviating anxiety and agitation
symptoms in patients with dementia, but no studies have examined the effects of muscle
relaxation therapy on cognitive function changes.
Therefore, the purpose of this study is to compare and validate the improvement of cognitive
function in patients with mild cognitive impairment and early alzheimer's dementia aged 50 to
85 years after performing muscle relaxation machine massage regularly.
The prevalence of dementia is approximately 5-10% in the elderly who are over 65 years of
age. In Korea, the prevalence of dementia among elderly people aged 65 and over was 9.18% in
2012, and the number of patients with dementia was estimated to be 540,755 (155,955 for male,
384,800 for female). The number of patients with dementia will be doubled every 20 years
until 2050, which is estimated to be 840,000 in 2020, about 1.27 million in 2030, and 2.71
million in 2050. Alzheimer's disease is the most common cause of dementia, accounting for
55-70% of all dementia. Major risk factors include age, genetic factors, apolipoprotein E
gene, female and brain trauma, but stress is also associated with increased risk of
Alzheimer's disease.
Stress can be present anywhere in our daily lives, and stress can energize life, but if
people are exposed to stress for a long time, they may develop physical symptoms. Severe and
long-term stress can cause or exacerbate diseases such as angina, stroke, hypertension,
diabetes, tension headache, back pain, irritable bowel syndrome, asthma and arthritis.
Studies about the relationship between stress and Alzheimer's disease have shown that the
corticotrophin releasing factor secreted when exposed to stress can increase brain toxic
protein such as beta amyloid plaques that are known to be responsible for dementia.
There are various ways to overcome stress, like meditation, yoga and relaxation training
methods that individuals can do at home. Relaxation training methods include relaxation using
breathing and progressive muscle relaxation. Progressive muscle relaxation therapy stabilizes
anxious psychology by stretching and relaxing several muscles of the body in turn. Muscle
relaxation promotes arterial and venous flow, lymphatic flow, reduces edema of muscles and
connective tissues, and improves organ function to aid homeostasis.
Muscle relaxation has been reported to be effective in alleviating anxiety and agitation
symptoms in patients with dementia, but no studies have examined the effects of muscle
relaxation therapy on cognitive function changes.
Therefore, the purpose of this study is to compare and validate the improvement of cognitive
function in patients with mild cognitive impairment and early alzheimer's dementia aged 50 to
85 years after performing muscle relaxation machine massage regularly.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04513106 -
Promoting Advance Care Planning for Persons With Early-stage Dementia in the Community: a Feasibility Trial
|
N/A | |
Recruiting |
NCT06011681 -
The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
|
||
Recruiting |
NCT04522739 -
Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease
|
Phase 4 | |
Active, not recruiting |
NCT03167840 -
Falls Prevention Through Physical And Cognitive Training in Mild Cognitive Impairment
|
N/A | |
Active, not recruiting |
NCT03676881 -
Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
|
||
Not yet recruiting |
NCT05041790 -
A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate Compared to Placebo in Patients With Degenerative Mild Cognitive Impairment
|
Phase 4 | |
Recruiting |
NCT04121156 -
High Definition Transcranial Direct Current Stimulation (HD-tDCS) in Patients With Mild Cognitive Impairment
|
N/A | |
Recruiting |
NCT03605381 -
MORbidity PRevalence Estimate In StrokE
|
||
Completed |
NCT02774083 -
Cognitive Training Using Feuerstein Instrumental Enrichment
|
N/A | |
Completed |
NCT01315639 -
New Biomarker for Alzheimer's Disease Diagnostic
|
N/A | |
Enrolling by invitation |
NCT06023446 -
Can (Optical Coherence Tomography) Pictures of the Retina Detect Alzheimer's Disease at Its Earliest Stages?
|
||
Completed |
NCT04567745 -
Automated Retinal Image Analysis System (EyeQuant) for Computation of Vascular Biomarkers
|
Phase 1 | |
Recruiting |
NCT05579236 -
Cortical Disarray Measurement in Mild Cognitive Impairment and Alzheimer's Disease
|
||
Completed |
NCT03583879 -
Using Gait Robotics to Improve Symptoms of Parkinson's Disease
|
N/A | |
Terminated |
NCT02503501 -
Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease
|
Phase 2 | |
Not yet recruiting |
NCT03740178 -
Multiple Dose Trial of MK-4334 in Participants With Alzheimer's Clinical Syndrome (MK-4334-005)
|
Phase 1 | |
Active, not recruiting |
NCT05204940 -
Longitudinal Observational Biomarker Study
|
||
Recruiting |
NCT02663531 -
Retinal Neuro-vascular Coupling in Patients With Neurodegenerative Disease
|
N/A | |
Recruiting |
NCT06150352 -
Sleep Apnea, Neurocognitive Decline and Brain Imaging in Patients With Subjective or Mild Cognitive Impairment
|
||
Completed |
NCT04817176 -
MI-CBT Adherence Program for Lifestyle Interventions in Older Adults
|
Early Phase 1 |